Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 15.1 M13.91 M15.72 M17.75 M19.24 M 66.62 M Research & development ————— — Operating income 32.63 M37.35 M37.77 M33.5 M33.39 M 142.01 M Non-Operating Income, Total -22.11 M-22.05 M-30.39 M-20.43 M-19.98 M -92.84 M Interest expense, net of interest capitalized 23.18 M23.05 M22.46 M21.96 M21.02 M 88.49 M Non-Operating Income, excl. Interest Expenses -23.21 M-23.05 M-34.94 M-21.96 M-21.02 M -100.97 M Unusual income/expense 1.11 M1.01 M4.55 M1.53 M1.03 M 8.13 M Pretax income -12.66 M-7.75 M-15.08 M46.28 M-7.61 M 15.84 M Equity in earnings ————— — Taxes 2.25 M4.42 M-20.2 M4.13 M3.65 M -8.01 M Non-controlling/minority interest 0000— — After tax other income/expense 20 K208 K-98 K163 K204 K 477 K Net income before discontinued operations 8.27 M10.88 M27.59 M8.95 M9.76 M 57.17 M Discontinued operations ————— — Net income 8.27 M10.88 M27.59 M8.95 M9.76 M 57.17 M Dilution adjustment 0000— — Preferred dividends 0000— — Diluted net income available to common stockholders 8.27 M10.88 M27.59 M8.95 M9.76 M 57.17 M Basic earnings per share (Basic EPS) 0.10.140.340.120.12 0.72 Diluted earnings per share (Diluted EPS) 0.10.140.340.10.12 0.7 Average basic shares outstanding 78.77 M78.98 M80.33 M79.8 M81.37 M — Diluted shares outstanding 79.86 M79.84 M81.12 M81.47 M83.65 M — EBITDA 46.4 M51.44 M52.89 M53.69 M51.01 M 209.03 M EBIT 32.63 M37.35 M37.77 M33.5 M33.39 M 142.01 M Cost of revenue 137.35 M147.4 M146.68 M146.88 M150.79 M 591.75 M Other cost of goods sold 137.35 M147.4 M146.68 M146.88 M150.79 M 591.75 M Depreciation & amortization (cash flow) 13.78 M14.09 M15.12 M20.19 M17.61 M 67.02 M